These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23540593)

  • 1. Rituximab in the treatment of primary cutaneous B-cell lymphoma: a review.
    Fernández-Guarino M; Ortiz-Romero PL; Fernández-Misa R; Montalbán C
    Actas Dermosifiliogr; 2014 Jun; 105(5):438-45. PubMed ID: 23540593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab plus liposomal pegylated doxorubicin in the treatment of primary cutaneous B-cell lymphomas.
    Fabbri A; Cencini E; Alterini R; Rubegni P; Rigacci L; Delfino C; Puccini B; Fimiani M; Bosi A; Bocchia M; Pimpinelli N;
    Eur J Haematol; 2014 Aug; 93(2):129-36. PubMed ID: 24635751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous regression of primary diffuse large B-cell lymphoma, leg type.
    Alcántara-González J; González-García C; Fernández-Guarino M; Jaén-Olasolo P
    Actas Dermosifiliogr; 2014; 105(1):78-83. PubMed ID: 23098572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of intravenous therapy with rituximab in patients with primary cutaneous B-cell lymphomas.
    Brandenburg A; Humme D; Terhorst D; Gellrich S; Sterry W; Beyer M
    Br J Dermatol; 2013 Nov; 169(5):1126-32. PubMed ID: 23796422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cutaneous follicular center B-cell lymphoma treated with intralesional rituximab].
    Gamo R; Calzado L; Pinedo F; López-Estebaranz JL
    Actas Dermosifiliogr; 2008 May; 99(4):291-6. PubMed ID: 18394405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Focal rituximab-induced edematous reaction at primary cutaneous follicle center lymphoma lesions: case report and literature review.
    Brunet-Possenti F; Franck N; Tamburini J; Jacobelli S; Avril MF; Dupin N
    Dermatology; 2011; 223(3):200-2. PubMed ID: 21986026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic eight-cycle anti-CD20 monoclonal antibody (rituximab) therapy in primary cutaneous B-cell lymphomas--an applicational observation.
    Gellrich S; Muche JM; Wilks A; Jasch KC; Voit C; Fischer T; Audring H; Sterry W
    Br J Dermatol; 2005 Jul; 153(1):167-73. PubMed ID: 16029344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete remission of a primary cutaneous B-cell lymphoma of the lower leg by first-line monotherapy with the CD20-antibody rituximab.
    Bonnekoh B; Schulz M; Franke I; Gollnick H
    J Cancer Res Clin Oncol; 2002 Mar; 128(3):161-6. PubMed ID: 11935303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of radiation-relapsing primary cutaneous B-cell lymphoma with an anti-CD20 monoclonal antibody.
    Lacouture ME; Baron JM; Jani AB; Laumann AE; Soltani K
    Clin Exp Dermatol; 2005 Jan; 30(1):46-8. PubMed ID: 15663503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cutaneous B-cell lymphomas.
    Kempf W; Denisjuk N; Kerl K; Cozzio A; Sander C
    J Dtsch Dermatol Ges; 2012 Jan; 10(1):12-22; quiz 23. PubMed ID: 22212142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intralesional and intravenous treatment of cutaneous B-cell lymphomas with the monoclonal anti-CD20 antibody rituximab: report and follow-up of eight cases.
    Kerl K; Prins C; Saurat JH; French LE
    Br J Dermatol; 2006 Dec; 155(6):1197-200. PubMed ID: 17107389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rituximab in cutaneous B-cell lymphoma: a report of two cases.
    Sabroe RA; Child FJ; Woolford AJ; Spittle MF; Russell-Jones R
    Br J Dermatol; 2000 Jul; 143(1):157-61. PubMed ID: 10886152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in primary cutaneous B-cell lymphomas.
    Vermeer MH; Willemze R
    Curr Opin Oncol; 2014 Mar; 26(2):230-6. PubMed ID: 24463347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cutaneous B-cell lymphoma treatment with rituximab: two cases].
    Viguier M; Bachelez H; Brice P; Rivet J; Dubertret L
    Ann Dermatol Venereol; 2002 Oct; 129(10 Pt 1):1152-5. PubMed ID: 12442128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of primary cutaneous follicular centre lymphoma with rituximab: a report of two cases.
    Kennedy GA; Blum R; McCormack C; Prince HM
    Australas J Dermatol; 2004 Feb; 45(1):34-7. PubMed ID: 14961906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intralesional rituximab in the treatment of indolent primary cutaneous B-cell lymphomas: an epidemiological observational multicentre study. The Spanish Working Group on Cutaneous Lymphoma.
    Peñate Y; Hernández-Machín B; Pérez-Méndez LI; Santiago F; Rosales B; Servitje O; Estrach T; Fernández-Guarino M; Calzado L; Acebo E; Gallardo F; Salar A; Izu R; Ortiz-Romero PL; Pujol RM; Fernández-de-Misa R
    Br J Dermatol; 2012 Jul; 167(1):174-9. PubMed ID: 22356294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indolent primary cutaneous B-cell lymphoma: experience using systemic rituximab.
    Morales AV; Advani R; Horwitz SM; Riaz N; Reddy S; Hoppe RT; Kim YH
    J Am Acad Dermatol; 2008 Dec; 59(6):953-7. PubMed ID: 18817999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of cutaneous B-cell lymphoma: recommendations of the French cutaneous lymphoma study group].
    Grange F; D'Incan M; Ortonne N; Dalac S; Laroche L; Beylot-Barry M; Delfau-Larue MH; Vergier B; Bagot M;
    Ann Dermatol Venereol; 2010; 137(8-9):523-31. PubMed ID: 20804896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma.
    Heinzerling LM; Urbanek M; Funk JO; Peker S; Bleck O; Neuber K; Burg G; von Den Driesch P; Dummer R
    Cancer; 2000 Oct; 89(8):1835-44. PubMed ID: 11042581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regression of cutaneous intravascular lymphoma with rituximab.
    Han K; Haley JC; Carlson K; Pinter-Brown L; Soriano T
    Cutis; 2003 Aug; 72(2):137-40. PubMed ID: 12953938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.